financetom
Business
financetom
/
Business
/
Apple wants lower tariffs for smartphone makers in India, says report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apple wants lower tariffs for smartphone makers in India, says report
Jul 23, 2019 12:49 AM

US tech giant Apple is seeking lower tariffs for smartphone makers in the country, reported Financial Express.

The tech giant wants the Indian government to come up with a sector-specific policy to boost smartphone exports and address “disabilities” vis-a-vis China and Vietnam, sources told the newspaper.

The iPhone maker, the report said, has sought a globally “competitive tariff regime” that will enable manufacturers to export and sell smart-phones in the domestic market from a single facility.

The development comes at a time when authorities are looking forward to only allow imports of only telecom components that are not available in India at zero or concessional duties provided the finished products are re-exported.

The news also highlights the high tariff rates in the country that often hinders moves by manufacturers to set up plants in the country. According to the report, large foreign companies in India have to pay as high as 43.68 percent tax, whereas same companies in Vietnam enjoy preferential tax rates of 10 percent for 15 years or 17 percent for 10 years, compared with the regular rate of 20.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BP Appoints Meg O'Neill as Chief Executive Officer
BP Appoints Meg O'Neill as Chief Executive Officer
Mar 10, 2026
05:54 PM EST, 12/17/2025 (MT Newswires) -- BP (BP) said late Wednesday it appointed Meg O'Neill as chief executive officer, starting April 1, 2026. O'Neill will succeed Murray Auchincloss, who will step down as CEO and board director on Dec. 18. Auchincloss will continue in an advisory role until December 2026 to support the transition. Carol Howle, executive vice president...
Arcutis Biotherapeutics Insider Sold Shares Worth $332,851, According to a Recent SEC Filing
Arcutis Biotherapeutics Insider Sold Shares Worth $332,851, According to a Recent SEC Filing
Mar 10, 2026
05:57 PM EST, 12/17/2025 (MT Newswires) -- Patrick Burnett, Executive Vice President and Chief Medical Officer, on December 15, 2025, sold 11,500 shares in Arcutis Biotherapeutics ( ARQT ) for $332,851. Following the Form 4 filing with the SEC, Burnett has control over a total of 98,307 common shares of the company, with 98,307 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1787306/000174198725000010/xslF345X05/wk-form4_1766012033.xml...
FCC deletes reference to agency independence during US Senate hearing
FCC deletes reference to agency independence during US Senate hearing
Mar 10, 2026
(Adds comments by Trump, details, paragraphs 7-8 and 13, changes story identification tag used by some clients) * FCC website changed after questioning on agency's independence * Senator Lujan challenges FCC's independence claim * Trump's executive order restricts FCC's regulatory process By David Shepardson WASHINGTON, Dec 17 (Reuters) - The Federal Communications Commission on Wednesday deleted a longstanding reference to...
Kalaris Posts Positive Results from Macular Degeneration Drug Trial
Kalaris Posts Positive Results from Macular Degeneration Drug Trial
Mar 10, 2026
05:50 PM EST, 12/17/2025 (MT Newswires) -- Kalaris Therapeutics ( KLRS ) reported late Wednesday positive initial data from its Phase 1a trial of its investigational drug for treating naive neovascular AMD patients. The single ascending dose (SAD) trial showed the drug candidate, TH103, had clinically meaningful improvements in vision and retinal anatomy. The trial also indicated early signs of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved